CRIP2 and breast neoplasm: In a previous study, we established that the hypoxia-inducible factor-1 (HIF-1) pathway, a key mediator of the response to hypoxia, directly controls CRP2 transcriptional activation, and CRP2 expression is accordingly upregulated in hypoxic areas of breast tumors (Hoffmann et al., 2018).